Call Extraction: Phil & Meaghan — Urgent Platform Feedback Escalation

DDX ID: 1306 Date: 2026-02-04 Duration: ~25 minutes Participants: Phil Cranmer (CDL), Meaghan DePeter (MedScout CSM). Call type: Urgent product feedback escalation. Rob (newly promoted to lead all private practice) is frustrated with the platform. Phil is giving Meaghan “air cover” to escalate. Triage: Very rich. Org restructuring reveals updated leadership, and the platform adoption crisis is a commercial insight about what CDL actually needs from data tools to win.

Distinct Insights

1. Rob promoted to oversee ALL private practice — CDL’s national sales leadership is now two people

What: Phil: “Rob was recently promoted. So now he sits over all of private practice. So Dale and Scott and their teams now report up through Rob. Rob’s role will be backfilled. But now I’ve got him and Lynette running national sales for each of our two segments.”

So what: CDL’s sales organization has consolidated. Previously, Rob was West area VP (per 1137 training). Now he leads all private practice nationally, with Dale (East) and Scott (new name — private practice) reporting to him. Lynette leads all health systems nationally. This means CDL has exactly two national sales leaders below Phil, each owning one of the two commercial motions. Their opinions about data tools carry organizational weight — if either rejects a platform, their entire motion reverts. Rob’s promotion happened between the November 2025 trainings (where he was learning the platform as West AVP) and February 2026 (this call). His scope expanded dramatically while his platform frustration grew.

Speaker credibility: Phil, describing his own org. Company fact. Scope: Company-wide org structure. Motion: Both — the two-leader structure applies to both motions. Date note: Feb 2026. This updates the org structure from the Nov 2025 training sessions.

2. Explicit platform reversion threat — what CDL needs from data tools to stay

What: Phil: “It’s critical that I don’t lose Rob on this either… if I lose Rob and Lynette, dude, I’ll be going back to Acuity and paying for two platforms.” And: “if I’ve got my two sales leaders that are not bought into this, my boss eventually is going to come to me and be like, dude, you got to revert back.”

So what: CDL’s MedScout adoption is at risk as of February 2026. The threat isn’t about data quality (Phil validated the underlying data is valuable) or about capability (claims intelligence serves CDL’s targeting well). It’s about workflow friction — Rob can’t rapidly scan a map, see volumes, and qualify accounts without multiple clicks. The platform makes the right data hard to access quickly. This is a fingerprint insight because it reveals what CDL values in commercial data tools: not just what data is available, but how fast a field rep can extract actionable intelligence. The tool needs to match the speed of a rep’s decision-making process — scan territory, identify targets, drill into the best ones. If that takes 5 clicks instead of 1, the rep goes back to the old tool (Acuity) or a spreadsheet.

Speaker credibility: Phil, very direct and explicit. Not a negotiation tactic — he’s giving Meaghan ammunition to escalate internally. Scope: Company-wide adoption. Motion: Both (Rob = PP, Lynette = HS — both need to stay).

3. Volume trend analysis reveals sales opportunities — Dr. Smith example

What: Phil examining Dr. Michael Smith at Christus Trinity Clinic: 150 SPECT claims across 2024-2025, but 415 claims when 2023 is included. Phil: “2023 was a big volume year like 200… there was a change in trend from 23 to 24 in terms of billing.”

So what: A physician whose SPECT volume drops significantly year-over-year could signal equipment problems (the SPECT camera is aging or broken), competitive loss (patients shifted to another practice), retirement planning (winding down before leaving), or other changes that create a sales opening. In this case, Dr. Smith went from ~265 claims in 2023 to ~150 across two years — roughly a 45% drop. For CDL, that’s a lead: something changed at this practice, and change creates opportunity for CDL’s equipment placement or upgrade conversation. The insight isn’t just “look at volume trends” — it’s that downward volume trends at SPECT practices are specific buying signals for CDL’s offering. The frustration is that the platform makes this analysis harder than it should be due to inconsistent time frames across different views.

Speaker credibility: Phil, analyzing real data in real-time. The observation is sound — the specific cause of the drop is unknown and would require field investigation. Scope: Universal targeting methodology — volume drops are buying signals across all territories. Motion: Private practice (this specific example), but the methodology applies to hospitals too.

4. Phil’s strategy: direct reps to Strategies, away from Discovery

What: Phil: “I too can walk him off of the discovery functionality so long as we can bolster up strategy because my feedback to him will be dude, this is where you need your team focusing is in strategies for targeting purposes. Forget discovery for a minute.”

So what: Phil is making a deliberate trade-off: narrow the scope of what needs to work well (Strategy module) rather than trying to fix everything (Strategy + Discovery). Strategy has pre-built targeting filters (SPECT no-PET, private practice only, referral pathways) that match CDL’s actual commercial workflows. Discovery is open-ended exploration that reps may not need for daily targeting. By directing Rob’s team to Strategy, Phil (1) reduces the surface area of required platform improvements, (2) channels reps toward repeatable workflows rather than ad-hoc analysis, and (3) concentrates product team attention on the module that matters most. This also reveals that CDL thinks about data tools in terms of workflow efficiency — the tool should encode their targeting logic so reps execute a structured process, not reinvent it each time.

Speaker credibility: Phil, describing his management approach. High. Scope: Company-wide platform usage direction. Motion: Both.

5. Jeff (new hire) as potential advocate — fresh eyes without legacy habits

What: Meaghan: “The new hire, Jeff was also on the call. He asked some really great questions and I could see that he was poking around and exploring… even though he was on that call with Rob which was fully like, you know, this doesn’t work and we want to change this, I did get some positive feedback.” Phil: “Put your arms around him, give him some love, make him an advocate.”

So what: Per the 1775 call (March 31, 2026), Jeff started at CDL in late January 2026 — meaning he joined AFTER the Acuity-to-MedScout transition was already underway. He likely has minimal or no Acuity experience, so he doesn’t have the “this was better before” comparison that Rob is reacting from. If MedScout can build Jeff into a proficient user quickly, his success becomes proof that the platform works — social evidence that undermines the “it doesn’t work” narrative from Rob. This is a standard adoption pattern: new users without legacy bias adopt faster and can become internal advocates if supported well. Phil explicitly asked Meaghan to cultivate Jeff as an advocate, which means Phil sees the adoption challenge as partly about internal perception management, not just feature gaps.

Speaker credibility: Meaghan (observation), Phil (strategic direction). Both credible. Scope: CDL adoption dynamics. Motion: Private practice (Jeff is a PP hire).

6. CDL annual meeting was in Nashville — organizational timing

What: Phil: company annual meeting was last week in Nashville. City got hit with 5 inches of snow but “by and large, most everyone got there” and “everything went well.”

So what: Useful for timeline: CDL’s annual meeting was late January 2026 in Nashville. Rob was West AVP as recently as November 2025 and is national PP leader by February 2026 — the annual meeting is the most likely venue for announcing the promotion, though this isn’t stated. The annual meeting’s timing (just before Phil’s platform escalation) may or may not be connected to his urgency — I’m inferring a link that Phil didn’t make explicit.

Speaker credibility: Phil, company event. Fact. Scope: Company timeline. Motion: Both.

Transcription Notes

Rob — full name not given in this transcript but previously identified as Robb Gosling from West area training. Now promoted to national PP leadership.
Scott — appears as reporting to Rob alongside Dale. New name for private practice leadership. May be Scot MacDonell from Central training (1152).
Jeff — new hire, showing promise. Last name not stated.
Christus Trinity Clinic — facility referenced in Dr. Smith analysis. Texas-based health system.
Shana — Meaghan’s manager at MedScout. Likely Shaina Smolowe (Head of CS).
Data timing: CMS through June 2025, clearinghouses full 2025 by end of first week of Feb 2026.